PO-1188: Optimal radiotherapy strategy as risk-group in non-metastatic prostate cancer patients (KROG 18-15). (November 2020) - Choi, S.H.; Kim, Y.S.; Yu, J.; Nam, T.; Kim, J.; Jang, B.; Kim, J.H.; Kim, Y.; Jung, B.K.; Chang, A.R.; Park, Y.; Lee, S.U.; et al.